Literature DB >> 10691298

Mice transgenic for a human amyloid precursor protein promoter-lacZ reporter construct.

K L Wright1, D G Morgan, X Yu, J R Goss, J M Salbaum, K Duff, M N Gordon.   

Abstract

Transgenic mouse lines were generated that expressed a 2-kb amyloid precursor protein (APP) promoter/beta-galactosidase reporter gene construction. In brain, hippocampal pyramidal neurons, neurons in the deeper layers of cerebral cortex, and neurons in several thalamic nuclei were heavily labeled by beta-galactosidase histochemistry. In general, molecular layers and white matter regions did not express the reporter gene. When compared with in situ hybridization for endogenous murine APP RNA, the striatum and outer layers of cerebral cortex had little reporter expression. Thus, the match between reporter expression and endogenous APP expression in brain was not perfect. A similar mismatch between the relative expression of the reporter gene and endogenous APP RNA distribution was found in homogenates from several organs. Although prior work in transgenic mice found similar mismatches in reporter gene distribution, none had tested the APP promoter construct in response to neuronal injury. Kainic acid injections successfully increased murine APP expression in the transgenic mice, but had no effect on the reporter gene expression. Based on these data and those collected by others, we conclude that the 2-kb region upstream of the APP transcription initiation site contains some elements responsible for the tissue-specific expression of this gene, but does not contain all the cis-acting elements sufficient for either the differential tissue distribution of this gene or the regulation of this gene subsequent to neural damage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10691298     DOI: 10.1385/jmn:13:1-2:111

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

1.  The amyloid beta-protein precursor promoter. A region essential for transcriptional activity contains a nuclear factor binding domain.

Authors:  W W Quitschke; D Goldgaber
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

2.  Expression of APP in the early stage of brain damage.

Authors:  T Kawarabayashi; M Shoji; Y Harigaya; H Yamaguchi; S Hirai
Journal:  Brain Res       Date:  1991-11-01       Impact factor: 3.252

3.  Complementary DNA for the mouse homolog of the human amyloid beta protein precursor.

Authors:  T Yamada; H Sasaki; H Furuya; T Miyata; I Goto; Y Sakaki
Journal:  Biochem Biophys Res Commun       Date:  1987-12-16       Impact factor: 3.575

4.  APP gene promoter constructs are preferentially expressed in the CNS and testis of transgenic mice.

Authors:  N W Fox; E M Johnstone; K E Ward; J Schrementi; S P Little
Journal:  Biochem Biophys Res Commun       Date:  1997-11-26       Impact factor: 3.575

5.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

6.  The upstream stimulatory factor functionally interacts with the Alzheimer amyloid beta-protein precursor gene.

Authors:  D M Kovacs; W Wasco; J Witherby; K M Felsenstein; F Brunel; R G Roeder; R E Tanzi
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

7.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

8.  Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression.

Authors:  W S Griffin; J G Sheng; S M Gentleman; D I Graham; R E Mrak; G W Roberts
Journal:  Neurosci Lett       Date:  1994-08-01       Impact factor: 3.046

9.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

10.  The promoter of Alzheimer's disease amyloid A4 precursor gene.

Authors:  J M Salbaum; A Weidemann; H G Lemaire; C L Masters; K Beyreuther
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.